| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.07 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |